Tim Coleman, Ph.D.

Vice President of Operations

Dr. Tim Coleman is responsible for leading operations at Immunomic Therapeutics. In this role, he is focused on internal expansion efforts and leading the chemistry, manufacturing and controls team. Dr. Coleman also played a key role in the successful out-licensing of LAMP-Vax allergy applications to Astellas Pharma.

Prior to joining the ITI team, he served as Senior Director of New Product Development at SeraCare Life Sciences in Gaithersburg, MD. Dr. Coleman also held leadership roles at Lonza Bioscience, Inc. where he oversaw product development and quality control departments as well as Human Genome Sciences where he helped establish the Protein Development department. Dr. Coleman has authored more than 40 publications and 26 issued patents. He obtained his B.A. degree from Rutgers University in Newark, New Jersey and a Ph.D. in Molecular and Cellular Biology from Ohio University.